NCT04252534View on ClinicalTrials.gov

Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions
Retinitis Pigmentosa
Interventions
COMBINATION_PRODUCT

PRP combined Magnovision

The rEMS helmet is used to stimulate the retina and visual pathways. (MagnovisionTM) combined with subtenon platelet rich plasma injection

BIOLOGICAL

PRP

Fresh autologous platelet rich plasma, injected subtenon space.

All Listed Sponsors
lead

Ankara Universitesi Teknokent

OTHER

NCT04252534 - Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma | Biotech Hunter | Biotech Hunter